XCXuan Cheng

Xuan Cheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuan Cheng has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Yaoyao Wang

    Department of Neurology, the first Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China

    4 shared publications
  • Yajun Lian

    Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    3 shared publications
  • Yidi Sun

    Department of Neurology, the first Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China

    3 shared publications
  • Haifeng Zhang

    Department of Neurology, the first Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China

    2 shared publications
  • Yimeng Li

    Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    2 shared publications
  • Wenchao Cheng

    Department of Neurology, the first Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China

    1 shared publication

Latest Publications

  • Open Access

    The Percentage of Neutrophils is Independently Associated with Blood-Brain Barrier(BBB) Disruption in Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD)

    by Xuan Cheng, Yidi Sun, Yaoyao Wang, Wenchao Cheng, Haifeng Zhang, Yan Jiang

    Purpose: This study aims to investigate the risk factors associated with blood-brain barrier(BBB) disruption in patients with myelin oligodendrocyte glycoprotein antibody associated disease(MOGAD). Patients and Methods: We collected clinical data from 95 patients diagnosed with MOGAD at the Department of Neurology, the First Affiliated Hospital of Zhengzhou University from October 2018 to May 2024. Patients were classified into normal or damaged BBB groups based on cerebrospinal fluid (CSF) albumin/serum albumin (QAlb). Binary logistic regression analysis was used to evaluate the risk factors for BBB disruption in MOGAD patients. Results: Our study revealed that in MOGAD patients with BBB damaged, there is a higher proportion of acute phase high EDSS scores, higher incidence of prodromal symptoms, and a higher rate of viral infections. Myelitis is the main clinical phenotype, with clinical manifestations primarily including limb weakness and bladder/bowel dysfunction. Laboratory tests showed higher levels of CSF protein, immunoglobulin (IgG), 24-hour intrathecal IgG synthesis rate, peripheral blood leukocytes, neutrophil percentage, NLR, anti-thyroglobulin antibodies(TGAbs), and fibrinogen levels, while free triiodothyronine (FT3) and lymphocyte percentage were lower. Multivariate regression analysis indicated that an increased neutrophil percentage is an independent risk factor for BBB damage in MOGAD patients (OR=1.068, 95% CI: 1.018– 1.122, P=0.008). Conclusion: Neutrophil percentage is a readily available and widely used indicator reflecting the immune system’s state and the body’s inflammation level. The change in neutrophil percentage is independently associated with BBB damage in MOGAD patients. This finding helps provide more reference information for personalized treatment decisions and further research into the pathogenesis of MOGAD.


  • Open Access

    Moyamoya syndrome secondary to hereditary spherocytosis: A case report

    by Yidi Sun, Yaoyao Wang, Yajun Lian, Xuan Cheng


  • Open Access

    The Neutrophil-to-Lymphocyte and Monocyte-to-Lymphocyte Ratios Are Independently Associated With the Severity of Autoimmune Encephalitis

    by Zhiwei Liu, Yimeng Li, Yaoyao Wang, Haifeng Zhang, Yajun Lian, Xuan Cheng

    Background: The neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) are biomarkers that may reflect inflammatory status in some immune-related diseases. This study aims to investigate the association of NLR and MLR with the severity and prognosis of autoimmune encephalitis (AE).Methods: A total of 199 patients diagnosed with AE in the First Affiliated Hospital of Zhengzhou University from October 2015 to October 2021 were retrospectively analyzed. The Clinical Assessment Scale for Autoimmune Encephalitis (CASE) and the modified Rankin Scale (mRS) were used to evaluate the severity of the patients at admission, and the patients were divided into mild group (CASE ≤ 4) and severe group (CASE ≥ 5) according to the CASE score. Poor prognosis was described as an mRS of 3 or more at 12 months. Binary logistic regression analysis was performed to assess risk factors for the severity and prognosis of AE.Results: NLR and MLR of severe group were significantly higher than that of mild group. NLR and MLR were positively correlated with the CASE score (r = 0.659, P < 0.001; r = 0.533, P < 0.001) and the mRS score (r = 0.609, P < 0.001;r = 0.478, P < 0.001) in AE patients. Multivariate logistic analysis showed that NLR (OR = 1.475, 95%CI: 1.211-1.796, P < 0.001) and MLR (OR = 15.228, 95%CI: 1.654-140.232, P = 0.016) were independent risk factors for the severity of AE. In addition, the CASE score and the mRS score were positively correlated (r = 0.849, P < 0.001). Multivariate logistic analysis showed that the CASE at admission (OR = 1.133, 95%CI: 1.043-1.229, P = 0.003) and age (OR = 1.105, 95%CI: 1.062-1.150, P < 0.001) were independent risk factors for the poor prognosis of AE patients. The NLR and MLR at admission and whether they decreased after immunotherapy were not associated with the prognosis of AE patients (P > 0.05).Conclusions: NLR and MLR, readily available and widespread inflammatory markers, were helpful for clinicians to monitor disease progression and identify potentially severe patients of AE early to optimize clinical treatment decisions.